Life Science Tools Market to Exceed US$ 95.68 Bn by 2027 | Says Precedence Research

According to Precedence Research, during the forecast period of 2020 to 2027, the global life science tools market is estimated to develop at a compound annual growth rate (CAGR) of 8.5%. The global life science tools market was valued at USD 49.82 billion in 2019, and it is predicted to exceed USD 95.68 billion by 2027. The study investigates several elements and their consequences on the growth of the life science tools market.

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1064

Growth Factor

The availability of better instruments and improved reagents has speed up the research and development process of drug. Rising investments in the development of bleeding edge technologies that improves life science instruments expected to trigger the growth of life science tools during the analysis period. In addition, prevalence of cancer and other major diseases also fuel the need for genomic analysis to early diagnose and cure the disease. Increasing cases of genetic disorder and birth defects have also prominently triggers the demand for life science tools in the near future. World Health Organization (WHO) has also quoted that prevalence of single gene disease at the time of birth is approximately 10 out of 1000 across the world.

Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1064

This report focuses on life science tools market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall life science tools market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Report Highlights

• In 2019, North America accounted for the maximum revenue share in 2019 due to local presence of major market leaders such as Thermo Fisher Scientific. Reputable informatics network along with well-regulated framework for approval and usage of genomic tests in the region again propel the growth of market.
• The Asia Pacific poised to witness the fastest growth during the analysis period. This is attributed to the increasing penetration of leading market players in emerging Asian countries and rising investments for design of advanced diagnostic methods.
• Cell biology technology dominated the global life science tools market in 2019 and followed by genomics technology in terms of revenue share. Besides this, proteomics application segment projected to register the highest growth over the forecast period. This is attributed to complete illustration provided by the proteome analysis related to structural and functional information of the cell as well as their response mechanisms against drugs and other outside factors.
• Based on product, separation technologies accounted for the major market value share in 2019. However, nucleic acid microarray segment predicted to register the fastest growth over the forecast period.
• The healthcare segment occupied maximum market value share in 2019 and expected to witness substantial growth over the forecast period. Rising adoption of proteomic and genomic workflow in hospitals to treat and diagnose various clinical abnormalities analyzed to fuel the market growth. However, biopharmaceutical companies expected to grow at a lucrative CAGR during the forecast period. These companies have initiated large number of genome sequencing projects by collaborating with academic medical centers and community health systems that account for its significant growth during the forecast period.

In-Depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of life science tools, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of life science tools has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the life science tools market.

Some of the prominent players in the life science tools market include:

• Agilent Technologies
• Becton, Dickinson and Company
• Hoffmann-La Roche Ltd.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Danaher Corporation
• GE Healthcare
• Hitachi, Ltd.
• Illumina, Inc.
• Merck KGaA
• Oxford Instruments plc
• Qiagen N.V.
• Shimadzu Corporation
• Thermo Fisher Scientific, Inc.
• ZEISS International

Segments Covered in the Report

By Technology

• Genomic Technology
• Cell Biology Technology
• Proteomics Technology
• Lab Supplies & Technologies
• Other Analytical & Sample Preparation Technology

By Product

• NGS
• Sanger Sequencing
• Nucleic Acid Preparation
• Nucleic Acid Microarray
• PCR & qPCR
• Flow Cytometry
• Mass Spectrometry
• Separation Technologies
• Electron Microscopy
• NMR
• Others

By End-User

• Biopharmaceutical Company
• Government & Academic
• Industry
• Health Care
• Others

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Some of the important ones are:

• What can be the best investment choices for venturing into new product and service lines?
• What value propositions should businesses aim at while making new research and development funding?
• Which regulations will be most helpful for stakeholders to boost their supply chain network?
• Which regions might see the demand maturing in certain segments in near future?
• What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
• Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
• Which government regulations might challenge the status of key regional markets?
• How will the emerging political and economic scenario affect opportunities in key growth areas?
• What are some of the value-grab opportunities in various segments?
• What will be the barrier to entry for new players in the market?

Table of Contents

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Technology Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Life Science Tools Market, By Product

7.1. Life Science Tools Market, by Product Type, 2020-2027
7.1.1. NGS
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Sanger Sequencing
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Nucleic Acid Preparation
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Nucleic Acid Microarray
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. PCR & qPCR
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Flow Cytometry
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Mass Spectrometry
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. Separation Technologies
7.1.8.1. Market Revenue and Forecast (2016-2027)
7.1.9. Electron Microscopy
7.1.9.1. Market Revenue and Forecast (2016-2027)
7.1.10. NMR
7.1.10.1. Market Revenue and Forecast (2016-2027)
7.1.11. Others
7.1.11.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global Life Science Tools Market, By End-User

8.1. Life Science Tools Market, by End-User, 2020-2027
8.1.1. Biopharmaceutical Company
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Government & Academic
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Industry
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Health Care
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Life Science Tools Market, By Technology

9.1. Life Science Tools Market, by Technology, 2020-2027
9.1.1. Genomic Technology
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Cell Biology Technology
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Proteomics Technology
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Lab Supplies & Technologies
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Other Analytical & Sample Preparation Technology
9.1.5.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Life Science Tools Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.2. Market Revenue and Forecast, by End-User (2016-2027)
10.1.3. Market Revenue and Forecast, by Technology (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.1.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.1.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.2. Market Revenue and Forecast, by End-User (2016-2027)
10.2.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.2.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.2.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.6.2. Market Revenue and Forecast, by End-User (2016-2027)
10.2.6.3. Market Revenue and Forecast, by Technology (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.7.2. Market Revenue and Forecast, by End-User (2016-2027)
10.2.7.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.2. Market Revenue and Forecast, by End-User (2016-2027)
10.3.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.3.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.3.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.6.2. Market Revenue and Forecast, by End-User (2016-2027)
10.3.6.3. Market Revenue and Forecast, by Technology (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.7.2. Market Revenue and Forecast, by End-User (2016-2027)
10.3.7.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.4.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.4.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.6.2. Market Revenue and Forecast, by End-User (2016-2027)
10.4.6.3. Market Revenue and Forecast, by Technology (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.7.2. Market Revenue and Forecast, by End-User (2016-2027)
10.4.7.3. Market Revenue and Forecast, by Technology (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.5.3. Market Revenue and Forecast, by Technology (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.4.2. Market Revenue and Forecast, by End-User (2016-2027)
10.5.4.3. Market Revenue and Forecast, by Technology (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.5.2. Market Revenue and Forecast, by End-User (2016-2027)
10.5.5.3. Market Revenue and Forecast, by Technology (2016-2027)

Chapter 11. Company Profiles

11.1. Agilent Technologies
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Becton, Dickinson and Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Hoffmann-La Roche Ltd.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bio-Rad Laboratories, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Bruker Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Danaher Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. GE Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Hitachi, Ltd.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Illumina, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Merck KGaA
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Oxford Instruments plc
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Qiagen N.V.
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Shimadzu Corporation
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Thermo Fisher Scientific, Inc.
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. ZEISS International
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1064

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com